
Investors must take note of Nektar Therapeutics’s (NKTR) performance last week, which was -26.42%.
Nektar Therapeutics (NASDAQ: NKTR) kicked off on Monday, down -12.01% from the previous trading day, before settling in for the closing price of $9.99. Over